FDA FORM 3398.pdf
FDA Form PDF 218 KB Posted
- Attached to
- Whole Exome Sequencing
- Solicitation number
- NCTR-2024-121391
About this file
This document includes a federal contract solicitation for whole exome sequencing services and a related contractor non-disclosure agreement form. The solicitation requires sequencing of 120 plasma samples from COVID-19 patients to identify novel circulating microRNAs and potential predictive biomarkers. Services must utilize an HTG EdgeSeq system for extraction-free sample preparation and simultaneous quantitative detection of approximately 2,000 microRNA transcripts from a small plasma volume. The vendor must deliver sequencing data in Excel format within 30-60 days of sample receipt. Responses are due by January 25, 2023. In addition, the contractor must sign the attached non-disclosure agreement form to protect any non-public information received during contract performance.
View the file
Other versions and copies of FDA Form 3398
Show all 20
Who attaches FDA Form 3398
Other files
| File | Type | Posted |
|---|---|---|
| Request For Quote NCTR-2024-121391.doc | DOC document | |
| Request For Quote NCTR-2023-121391.doc | DOC document | |
| Request For Quote NCTR-2023-121391.doc | DOC document | |
| Combined Synopsis Solicitation NCTR-2023-118263.docx | DOCX document | |
| Combined Synopsis Solicitation NCTR-2023-118263.docx | DOCX document | |
| Combined Synopsis Solicitation NCTR-2023-118263.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
FDA FORM 3398
CONTRACTOR’S COMMITMENT TO PROTECT
NON-PUBLIC INFORMATION (NPI) AGREEMENT
Whereas access to non-public information (NPI) from the files of the Food and Drug
Administration (FDA) is required in the performance of my official duties, under subsequent
Contract / Purchase Order, between FDA, and my employer _________________________________, I, ___________________________________ , hereby agree that I shall not further release, publish or disclose such information and I shall protect such information entrusted to me in accordance with the provisions of 21 U.S.C. § 331(j), 21 U.S.C. § 360(j), 18 U.S.C. § 1905, as well as other applicable statutory and regulatory provisions.
Further, I agree to:
1. Store NPI in the secured offices of the FDA or in FDA approved contractor facility containers if work is performed off an FDA site.
2. Grant access to NPI only to known employees of the FDA or to other persons designated in writing by the FDA.
3. Return all NPI and any pertinent notes to the FDA Project Officer I am assigned to upon completion of the contract, or at any time upon the FDA’s request.
4. Report in writing to the FDA Project Officer I am assigned to, all incidents in which unauthorized persons may have gained access to any NPI entrusted to me.
I understand the provisions of 21 U.S.C. § 331(j), 21 U.S.C. § 360(j), 18 U.S.C. § 1905 and that I am subject to criminal penalties prescribed by law for any violation thereof.
Signature: ___________________________________________ Date: ______________
Type or Print Name: ___________________________________
Witnessed by: ________________________________________ Date: ______________
Type or Print Name: ___________________________________
File details come from the government source that posted it. Updated .